Ladenburg Thalmann Upgrades Repros Therapeutics (RPRX) to Buy

November 16, 2016 7:53 AM EST
Get Alerts RPRX Hot Sheet
Price: $1.54 --0%

Rating Summary:
    4 Buy, 2 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 19 | New: 6
Trade RPRX Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Ladenburg Thalmann upgraded Repros Therapeutics (NASDAQ: RPRX) from Neutral to Buy with a price target of $5.50.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $1.88 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot Upgrades, Upgrades

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment